SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 76 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $15,000 | +7.1% | 27,782 | +75.1% | 0.00% | – |
Q4 2015 | $14,000 | +16.7% | 15,864 | +11.1% | 0.00% | – |
Q3 2015 | $12,000 | -58.6% | 14,276 | +46.2% | 0.00% | – |
Q2 2015 | $29,000 | -88.9% | 9,763 | -90.9% | 0.00% | – |
Q1 2015 | $262,000 | -96.0% | 106,928 | -95.8% | 0.00% | -100.0% |
Q4 2014 | $6,568,000 | -71.8% | 2,575,572 | -20.9% | 0.01% | -75.0% |
Q3 2014 | $23,263,000 | +4515.7% | 3,258,099 | +4107.6% | 0.02% | +2300.0% |
Q2 2014 | $504,000 | +362.4% | 77,434 | +368.7% | 0.00% | – |
Q1 2014 | $109,000 | – | 16,522 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |